CHIRANJIT GHOSH

Dr. CHIRANJIT GHOSH

Dept of Biotechnology, Manipal Institute of Technology, Manipal, India
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SJSubhra Jana
Subhra Jana
SDSankar Das
Sankar Das
CHIRANJIT GHOSHCHIRANJIT GHOSH
CHIRANJIT GHOSH
AMAbhijit Maity
Abhijit Maity
MPManik Pradhan
Manik Pradhan
With the aim to capture and subsequent selective trapping of CO2, a nanocomposite has been developed through selective modification of the outer surface of the halloysite nanotubes (HNTs) with an organosilane to make the nanocomposite a novel solid-phase adsorbent to adsorb CO2 from the atmosphere at standard ambient temperature and pressure. The preferential adsorption of three major abundant isotopes of CO2 (12C16O2, 13C16O2 and 12C16O18O) from the ambient air by amine functionalized HNTs has been explored using an optical cavity-enhanced integrated cavity output spectroscopy. CO2 adsorption/desorption cycling measurements demonstrate that the adsorbent can be regenerated at relatively low temperature and thus, recycled repeatedly to capture atmospheric CO2. The amine grafted halloysite shows excellent stability even in oxidative environments and has high efficacy of CO2 capture, introducing a new route to the adsorption of isotope selective atmospheric CO2.

29 August 2024 in RSC Advances
Verified
Journal Article
Open access
PDF file
KSKeerthana S.
Keerthana S.
GIGouri Illanad
Gouri Illanad
SSSwikriti Saket
Swikriti Saket
CHIRANJIT GHOSHCHIRANJIT GHOSH
CHIRANJIT GHOSH
Application of solid-phase microextraction technique in environmental research.

11 December 2019 in Journal of Separation Science
Verified
Journal Article
Closed access
PDF file
CHIRANJIT GHOSHCHIRANJIT GHOSH
CHIRANJIT GHOSH
VSVaroon Singh
Varoon Singh
JGJonathan Grandy
Jonathan Grandy
JPJanusz Pawliszyn
Janusz Pawliszyn

19 June 2014 in Journal of Breath Research
Verified
Journal Article
Closed access
CHIRANJIT GHOSHCHIRANJIT GHOSH
CHIRANJIT GHOSH
AMAbhijit Maity
Abhijit Maity
GBGourab D Banik
Gourab D Banik
SSSuman Som
Suman Som
ACArpita Chakraborty
Arpita Chakraborty
MPManik Pradhan
Manik Pradhan
We report, for the first time, the clinical feasibility of a novel residual gas analyzer mass spectrometry (RGA-MS) method for accurate evaluation of the (13)C-glucose breath test ((13)C-GBT) in the diagnosis of pre-diabetes (PD) and type 2 diabetes mellitus (T2D). In T2D or PD, glucose uptake is impaired and results in blunted isotope enriched (13)CO2 production in exhaled breath samples. Using the Receiver operating characteristics (ROC) curve analysis, an optimal diagnostic cut-off point of the (13)CO2/(12)CO2 isotope ratios expressed as the delta-over-baseline (DOB) value, was determined to be δDOB(13)C‰ = 28.81‰ for screening individuals with non-diabetes controls (NDC) and pre-diabetes (PD), corresponding to a sensitivity of 100% and specificity of 94.4%. We also determined another optimal diagnostic cut-off point of δDOB(13)C‰ = 19.88‰ between individuals with PD and T2D, which exhibited 100% sensitivity and 95.5% specificity. Our RGA-MS methodology for the (13)C-GBT also manifested a typical diagnostic positive and negative predictive value of 96% and 100%, respectively. The diagnostic accuracy, precision and validity of the results were also confirmed by high-resolution optical cavity enhanced integrated cavity output spectroscopy (ICOS) measurements. The δDOB(13)C‰ values measured with RGA-MS method, correlated favourably (R(2) = 0.979) with those determined by the laser based ICOS method. Moreover, we observed that the effects of endogenous CO2 production related to basal metabolic rates in individuals were statistically insignificant (p = 0.37 and 0.73) on the diagnostic accuracy. Our findings suggest that the RGA-MS is a valid and sufficiently robust method for the (13)C-GBT which may serve as an alternative non-invasive point-of-care diagnostic tool for routine clinical practices as well as for large-scale diabetes screening purposes in real-time.

1 June 2021 in Clinics In Laboratory Medicine
Verified
Journal Article
Closed access
CHIRANJIT GHOSHCHIRANJIT GHOSH
CHIRANJIT GHOSH
ALArmando Leon
Armando Leon
SKSeena Koshy
Seena Koshy
OAObadah Aloum
Obadah Aloum
YAYazan Al-Jabawi
Yazan Al-Jabawi
Sophia KooSophia Koo
Sophia Koo

12 February 2020 in RSC Advances
Verified
Journal Article
Open access
PDF file
CHIRANJIT GHOSHCHIRANJIT GHOSH
CHIRANJIT GHOSH
VSVaroon Singh
Varoon Singh
JGJonathan Grandy
Jonathan Grandy
JPJanusz Pawliszyn
Janusz Pawliszyn
Butylated hydroxytoluene (BHT) is widely used as a stable and inexpensive antioxidant in skin care products. BHT is effective at penetrating the epidermis, and prolonged exposure to BHT has been reported to have toxic effects on the lungs, liver, and kidneys. Given that the carcinogenic factor of BHT is closely related to the dose and the length of exposure of the compound on a specific organ, quantitative estimation of BHT in BHT-containing cosmetics is very important in terms of quality control measurements for products used in daily life. In this study, we have developed a new method based on purge-and-trap technology using a headspace needle trap device (NTD) in addition to a comparative SPME methodology which was both coupled to portable gas chromatography (GC) toroidal ion trap mass spectrometer (MS) for rapid determination of BHT in cosmetics. The sample was placed in a glass vial and heated to 60 °C for 30 min to promote partitioning of BHT into the headspace, where it was then pre-concentrated by the Tenax/carboxen NTD. To verify these results, a divinylbenzene/polydimethylsiloxane SPME fiber was also used for headspace extraction. To quantify BHT in a sample, a standard addition calibration method was employed. A six-point calibration curve showed high linearity (R2 = 0.98) within a dynamic concentration range of 1000–10 000 ng mL−1 BHT in the sample matrix. Estimation of BHT by NTD yielded a concentration value of around 5000 ng/0.1 g body lotion, whereas the measurement of BHT using the SPME method yielded a value of around 5500 ng/0.1 g body lotion. The attained results indicate that the amount of BHT estimated by the proposed needle trap method was well-matched with the standard SPME technique. The results obtained from both methods were well matched (∼90%). One of the advantages imparted by this method is that it is based on headspace sampling instead of direct extraction of BHT via direct immersion into the sample matrix; as such, the method does not contaminate the instrument after sampling. Moreover, the use of a portable GC-MS enables on-site quality control measurements of healthcare products, thus circumventing the need for transportation and laborious laboratory sample preparation protocols.